Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 10 to 14 Men only

Testosterone treatment for boys with Klinefelter syndrome during puberty

Official title: Klinefelter Syndrome - the Effect of Testosterone Treatment in Puberty. a Randomized, Double-blind Placebo-controlled Intervention Study: 'The TiPY Study'

Run by Copenhagen University Hospital, Rigshospitalet · NCT06294990 · Data updated 2026-11-12

This study tests if giving testosterone gel to boys aged 10-14 with Klinefelter syndrome can help improve their growth, body health, and brain development during puberty.

More Klinefelter Syndrome trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages10 Years to 14 Years
SexMen only
Enrollment32 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations1 site (Copenhagen)
StatusRecruiting
StartedAugust 15, 2024
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedFebruary 19, 2025
Trial IDNCT06294990 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are boys aged 10-14 diagnosed with Klinefelter syndrome and exhibiting specific hormonal profiles.

Probably not a fit

Patients with contraindications to testosterone treatment or those currently participating in other clinical trials may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of testosterone replacement therapy on boys aged 10-14 with Klinefelter syndrome (KS, 47,XXY). Participants will be randomly assigned to receive either testosterone gel or a placebo for two years. The study aims to assess how testosterone treatment influences body fat, metabolism, growth, bone health, and neurocognitive development. The findings could provide critical insights into the management of KS during a crucial developmental period.

Why it matters

Potential benefit: If successful, this treatment could significantly improve health outcomes and quality of life for boys with Klinefelter syndrome.

How similar studies have gone: While testosterone treatment in puberty for Klinefelter syndrome has been debated, this study aims to provide much-needed evidence, as similar approaches have not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 47,XXY Klinefelter syndrome
* Age 10-14 years at inclusion
* Luteinizing Hormone \> +2 standard deviations (SD) by ultrasensitive luteinizing hormone assay
* Free Testosterone\<+2 standard deviations
* Signed consent from parents

Exclusion Criteria:

* Previous or ongoing T treatment except for TRT because of micropenis
* Contraindications to testosterone treatment known hypersensitivity to testosterone or to any other constituent of the gel known or suspected prostatic cancer or breast carcinoma
* Participation in any other clinical trial

Where it's running

  • Copenhagen University Hospital, Rigshospitalet
    Copenhagen, Denmark
    Recruiting

Study contacts

  • Principal investigator: Lise Aksglaede, MD — Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
  • Study coordinator: Lise Aksglaede, MD
  • Email: lise.aksglaede@regionh.dk
  • Phone: +45 35455064

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.